291 related articles for article (PubMed ID: 28821582)
1. Identification of α-enolase as a prognostic and diagnostic precancer biomarker in oral submucous fibrosis.
Bag S; Dutta D; Chaudhary A; Sing BC; Pal M; Ray AK; Banerjee R; Paul RR; Basak A; Das AK; Chatterjee J
J Clin Pathol; 2018 Mar; 71(3):228-238. PubMed ID: 28821582
[TBL] [Abstract][Full Text] [Related]
2. Connecting cyto-nano-architectural attributes and epithelial molecular expression in oral submucous fibrosis progression to cancer.
Bag S; Pal M; Chaudhary A; Das RK; Paul RR; Sengupta S; Chatterjee J
J Clin Pathol; 2015 Aug; 68(8):605-13. PubMed ID: 26038241
[TBL] [Abstract][Full Text] [Related]
3. MALDI imaging reveals NCOA7 as a potential biomarker in oral squamous cell carcinoma arising from oral submucous fibrosis.
Xie X; Jiang Y; Yuan Y; Wang P; Li X; Chen F; Sun C; Zhao H; Zeng X; Jiang L; Zhou Y; Dan H; Feng M; Liu R; Chen Q
Oncotarget; 2016 Sep; 7(37):59987-60004. PubMed ID: 27509054
[TBL] [Abstract][Full Text] [Related]
4. Quantitative proteomic analysis for novel biomarkers of buccal squamous cell carcinoma arising in background of oral submucous fibrosis.
Liu W; Zeng L; Li N; Wang F; Jiang C; Guo F; Chen X; Su T; Xu C; Zhang S; Fang C
BMC Cancer; 2016 Aug; 16():584. PubMed ID: 27485544
[TBL] [Abstract][Full Text] [Related]
5. Expression pattern of DKK3, dickkopf WNT signaling pathway inhibitor 3, in the malignant progression of oral submucous fibrosis.
Zhou S; Zhu Y; Mashrah M; Zhang X; He Z; Yao Z; Zhang C; Guo F; Hu Y; Zhang C
Oncol Rep; 2017 Feb; 37(2):979-985. PubMed ID: 27959428
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
7. Identification of over expressed proteins in oral submucous fibrosis by proteomic analysis.
Das T; Prodhan C; Patsa S; Ray JG; Chaudhuri K
J Cell Biochem; 2018 Jun; 119(6):4361-4371. PubMed ID: 28980718
[TBL] [Abstract][Full Text] [Related]
8. Comparison of microvessel density using CD34 and CD105 in oral submucous fibrosis and its correlation with clinicopathological features: An immunohistochemical study.
Pammar C; Nayak RS; Kotrashetti VS; Hosmani J
J Cancer Res Ther; 2018; 14(5):983-988. PubMed ID: 30197335
[TBL] [Abstract][Full Text] [Related]
9. Correlated analysis of semi-quantitative immunohistochemical features of E-cadherin, VEGF and CD105 in assessing malignant potentiality of oral submucous fibrosis.
Anura A; Das RK; Pal M; Paul RR; Ray AK; Chatterjee J
Pathol Res Pract; 2014 Dec; 210(12):1054-63. PubMed ID: 25015036
[TBL] [Abstract][Full Text] [Related]
10. Ki67, CD105, and α-SMA Expression Supports Biological Distinctness of Oral Squamous Cell Carcinoma Arising in the Background of Oral Submucous Fibrosis.
Gadbail AR; Korde S; Chaudhary MS; Sarode SC; Gondivkar SM; Dande R; Tekade SA; Yuwanati M; Hande A; Patil S
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2067-2074. PubMed ID: 32711434
[TBL] [Abstract][Full Text] [Related]
11. Cyclophilin A was revealed as a candidate marker for human oral submucous fibrosis by proteomic analysis.
Hou X; Liu R; Huang C; Jiang L; Zhou Y; Chen Q
Cancer Biomark; 2017 Sep; 20(3):345-356. PubMed ID: 28826174
[TBL] [Abstract][Full Text] [Related]
12. Profiling of chromosomal changes in potentially malignant and malignant oral mucosal lesions from South and South-East Asia using array-comparative genomic hybridization.
Lunde ML; Roman E; Warnakulasuriya S; Mehrotra R; Laranne J; Vasstrand EN; Ibrahim SO
Cancer Genomics Proteomics; 2014; 11(3):127-40. PubMed ID: 24969693
[TBL] [Abstract][Full Text] [Related]
13. Survivin as a potential early marker in the carcinogenesis of oral submucous fibrosis.
Zhou S; Qu X; Yu Z; Zhong L; Ruan M; Ma C; Wang M; Zhang C; Jian X
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Apr; 109(4):575-81. PubMed ID: 20303055
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of oral squamous cell carcinoma with oral submucous fibrosis.
Saalim M; Sansare K; Karjodkar FR; Johaley S; Ali IK; Sharma SR; Mehra A; Rahman B
J Cancer Res Ther; 2021; 17(6):1510-1514. PubMed ID: 34916386
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of PTEN immunoexpression in oral submucous fibrosis: role in pathogenesis and malignant transformation.
Angadi PV; Krishnapillai R
Head Neck Pathol; 2012 Sep; 6(3):314-21. PubMed ID: 22392409
[TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of c-Jun in normal mucosa, oral submucous fibrosis, epithelial dysplasia, and oral squamous cell carcinoma: A comparative study.
Shraddha KS; Niranjan KC; Hallikeri K
J Cancer Res Ther; 2018; 14(6):1180-1183. PubMed ID: 30488826
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of stromal myofibroblasts in oral submucous fibrosis and its malignant transformation: An immunohistochemical study.
Liu Z; Hu W; Shan Z; Liu S; Yao Z; Quan H
J Cancer Res Ther; 2024 Apr; 20(2):706-711. PubMed ID: 38687943
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin: a marker for invasive oral squamous cell carcinoma but not for potentially malignant epithelial dysplasias.
Routray S; Kheur SM; Kheur M
Ann Diagn Pathol; 2013 Oct; 17(5):421-4. PubMed ID: 23711950
[TBL] [Abstract][Full Text] [Related]
20. Betel-derived alkaloid up-regulates keratinocyte alphavbeta6 integrin expression and promotes oral submucous fibrosis.
Moutasim KA; Jenei V; Sapienza K; Marsh D; Weinreb PH; Violette SM; Lewis MP; Marshall JF; Fortune F; Tilakaratne WM; Hart IR; Thomas GJ
J Pathol; 2011 Feb; 223(3):366-77. PubMed ID: 21171082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
